ATE36325T1 - Derivate von 5-halovinyl-2'-deoxyuridin. - Google Patents

Derivate von 5-halovinyl-2'-deoxyuridin.

Info

Publication number
ATE36325T1
ATE36325T1 AT83305456T AT83305456T ATE36325T1 AT E36325 T1 ATE36325 T1 AT E36325T1 AT 83305456 T AT83305456 T AT 83305456T AT 83305456 T AT83305456 T AT 83305456T AT E36325 T1 ATE36325 T1 AT E36325T1
Authority
AT
Austria
Prior art keywords
halovinyl
deoxyuridine
derivatives
bromine
chlorine
Prior art date
Application number
AT83305456T
Other languages
English (en)
Inventor
David Ian Carter Scopes
Roger Frank Newton
Paul Ravenscroft
Richard Clive Cookson
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Application granted granted Critical
Publication of ATE36325T1 publication Critical patent/ATE36325T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/03—Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
    • C07C43/04—Saturated ethers
    • C07C43/13—Saturated ethers containing hydroxy or O-metal groups
    • C07C43/135—Saturated ethers containing hydroxy or O-metal groups having more than one ether bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C62/00—Compounds having carboxyl groups bound to carbon atoms of rings other than six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C62/08—Saturated compounds containing ether groups, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/70—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with ring systems containing two or more relevant rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic System
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
AT83305456T 1982-09-17 1983-09-16 Derivate von 5-halovinyl-2'-deoxyuridin. ATE36325T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8226515 1982-09-17
EP83305456A EP0104066B1 (de) 1982-09-17 1983-09-16 Derivate von 5-Halovinyl-2'-deoxyuridin

Publications (1)

Publication Number Publication Date
ATE36325T1 true ATE36325T1 (de) 1988-08-15

Family

ID=10532974

Family Applications (1)

Application Number Title Priority Date Filing Date
AT83305456T ATE36325T1 (de) 1982-09-17 1983-09-16 Derivate von 5-halovinyl-2'-deoxyuridin.

Country Status (17)

Country Link
US (1) US4564618A (de)
EP (1) EP0104066B1 (de)
JP (1) JPS5980620A (de)
AT (1) ATE36325T1 (de)
AU (2) AU575022B2 (de)
CA (1) CA1257595A (de)
CZ (1) CZ402691A3 (de)
DE (1) DE3377647D1 (de)
DK (1) DK160271C (de)
ES (2) ES8502978A1 (de)
GB (1) GB2129425B (de)
HK (1) HK84190A (de)
IE (1) IE55921B1 (de)
MX (1) MX9203234A (de)
NZ (1) NZ205619A (de)
SG (1) SG68890G (de)
ZA (1) ZA836902B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4719214A (en) * 1985-07-25 1988-01-12 Southern Research Institute Carbocyclic analogues of thymine nucleosides
PT83201A (en) * 1985-08-16 1986-09-01 Glaxo Group Ltd Guanine derivatives
US5215970A (en) * 1987-04-16 1993-06-01 Medivir Ab Nucleosides and nucleotide analogues, pharmaceutical composition and processes for the preparation of the compounds
EP0516186A3 (en) * 1987-04-16 1993-01-13 Medivir Aktiebolag Nucleosides and nucleoside analogues, pharmaceutical composition and processes for the preparation of the compounds
US4863927A (en) * 1987-05-11 1989-09-05 Merck & Co., Inc. 1-(2-hydroxymethyl)cycloalkylmethyl)-5-substituted uracils
GB8920457D0 (en) * 1989-09-11 1989-10-25 Glaxo Group Ltd Chemical compounds
USH1142H (en) 1990-11-05 1993-02-02 Optically active cyclobutyl pyrimidine

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS606943B2 (ja) * 1975-04-01 1985-02-21 三井製薬工業株式会社 １−（α−アルコキシアルキル）−ウラシル類の製造法
US4177348A (en) * 1977-12-13 1979-12-04 United States Government Carbocyclic analogs of cytosine nucleosides
US4232154A (en) * 1977-12-13 1980-11-04 United States Of America Carbocyclic analogs of cytosine nucleosides exhibiting antiviral and antineoplasticactivity
GB1601020A (en) * 1978-04-24 1981-10-21 Stichting Grega Vzw 2'-deoxy-5 (2-halogenovinyl)-uridines
GB2060604B (en) * 1979-10-03 1983-11-23 Univ Birmingham And Stichting E15-(2-halogenovinyl)-2'-deoxycytidines
JPS5738774A (en) * 1980-08-19 1982-03-03 Chugai Pharmaceut Co Ltd Uracil derivative and its preparation
US4347360A (en) * 1980-09-16 1982-08-31 Ens Bio Logicals Inc. Ring open nucleoside analogues
NZ199764A (en) * 1981-03-20 1984-08-24 Beecham Group Plc 5-(2-halogenovinyl)-2'-deoxyuridine derivatives and pharmaceutical compositions
EP0072137A1 (de) * 1981-08-01 1983-02-16 Beecham Group Plc Antivirale Deoxyuridin-Derivate
US4396623A (en) * 1981-08-26 1983-08-02 Southern Research Institute Carbocyclic analogs of uracil nucleosides as antiviral agents
HU183567B (en) * 1981-09-07 1984-05-28 Mta Koezponti Kemiai Kutato In Process for preparing /e/-5-/2-bromo-vinyl/-uridine and derivatives thereof
JPS5843993A (ja) * 1981-09-09 1983-03-14 Yamasa Shoyu Co Ltd １−β−Ｄ−アラビノフラノシル−（Ｅ）−５−（２−ハロゲノビニル）ウラシル−５′−りん酸およびその製造法
EP0080305A1 (de) * 1981-11-19 1983-06-01 Beecham Group Plc Antivirale 2'-Deoxyuridine, ihre Herstellung und Verwendung
EP0082668A1 (de) * 1981-12-18 1983-06-29 Beecham Group Plc 5-(2-Halogenvinyl)-2'-Deoxyuridinderivate, Verfahren zu ihrer Herstellung, die sie enthaltende pharmazeutische Präparate und ihre Verwendung bei der Bekämpfung von viralen Infektionen
DE3620646A1 (de) * 1986-06-20 1987-12-23 Bayer Ag Verfahren zur herstellung von (1r, 4s)-4-hydroxy-2-cyclopentenylestern

Also Published As

Publication number Publication date
NZ205619A (en) 1987-09-30
AU1918583A (en) 1984-03-22
JPS5980620A (ja) 1984-05-10
US4564618A (en) 1986-01-14
ES532056A0 (es) 1985-08-01
EP0104066A3 (en) 1984-06-06
SG68890G (en) 1990-10-26
ES8506751A1 (es) 1985-08-01
EP0104066A2 (de) 1984-03-28
CA1257595A (en) 1989-07-18
DK422183D0 (da) 1983-09-16
AU1646588A (en) 1988-08-11
DK160271C (da) 1991-07-22
GB2129425A (en) 1984-05-16
DK160271B (da) 1991-02-18
AU575022B2 (en) 1988-07-21
IE832175L (en) 1984-03-17
GB8324813D0 (en) 1983-10-19
CZ402691A3 (en) 1993-07-14
ES525670A0 (es) 1985-02-01
EP0104066B1 (de) 1988-08-10
MX9203234A (es) 1992-07-01
CA1271199C (de) 1990-07-03
DE3377647D1 (de) 1988-09-15
DK422183A (da) 1984-03-18
AU601583B2 (en) 1990-09-13
ZA836902B (en) 1985-05-29
HK84190A (en) 1990-10-25
ES8502978A1 (es) 1985-02-01
GB2129425B (en) 1987-02-11
IE55921B1 (en) 1991-02-27

Similar Documents

Publication Publication Date Title
FI914928A0 (fi) Hydroximetyl (metylencyklopentyl) puriner och -pyrimidiner.
ATE45354T1 (de) Chinoloncarbonsaeurederivate.
DE3462894D1 (de) 3-indolecarboxamide compounds
ATE36325T1 (de) Derivate von 5-halovinyl-2'-deoxyuridin.
ES8800571A1 (es) Procedimiento para preparar un derivado de 1,3-oxazolidina-2-ona.
ES477785A1 (es) Procedimiento para la preparacion de nuevas 2-fenilimino- imidazolidinas sustituidas.
DE3673692D1 (de) Cytostatisch wirksame titanocen-komplexe.
NO902157L (no) Butensyrederivater for terapeutisk anvendelse.
FR2443460A1 (fr) Derives mercaptoacyles d'acides 4,5-dihydro-1h-pyrrole-2-carboxyliques et d'acides 1,4,5,6-tetrahydropyridine-2-carboxyliques, utiles comme agents hypotenseurs
ATE151987T1 (de) Verwendung von 3-pyridazinone zur verringerung der blutplätchenzahl
NO842003L (no) Substituerte isokinolinderivater
FR2361364A1 (fr) Nouveaux derives d'azetidine
ATE81465T1 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur behandlung von nierenkrankheiten.
TH2688EX (th) สารประกอบเบนโซอิลเยูเรียที่ใช้ฆ่าตัวรังควาน
ATE56445T1 (de) Pharmacologisch aktive propionylanilide.
SU1319521A1 (ru) 5-(2,2,2-Трифтор-1-окси-1-трифторметилэтил)фурил-2-метилгидразонийбромид, проявляющий антимикробную и противовоспалительную активность

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee